• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

土耳其三家大流行医院医护人员中 2019 年冠状病毒病(COVID-19)血清流行率。

Seroprevalence of coronavirus disease 2019 (COVID-19) among health care workers from three pandemic hospitals of Turkey.

机构信息

Genomic Laboratory (GLAB), Umraniye Teaching and Research Hospital, University of Health Sciences, Istanbul, Turkey.

Cerrahpasa Faculty of Medicine, Department of Nephrology, Istanbul University-Cerrahpasa, Istanbul, Turkey.

出版信息

PLoS One. 2021 Mar 3;16(3):e0247865. doi: 10.1371/journal.pone.0247865. eCollection 2021.

DOI:10.1371/journal.pone.0247865
PMID:33657142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7928442/
Abstract

COVID-19 is a global threat with an increasing number of infections. Research on IgG seroprevalence among health care workers (HCWs) is needed to re-evaluate health policies. This study was performed in three pandemic hospitals in Istanbul and Kocaeli. Different clusters of HCWs were screened for SARS-CoV-2 infection. Seropositivity rate among participants was evaluated by chemiluminescent microparticle immunoassay. We recruited 813 non-infected and 119 PCR-confirmed infected HCWs. Of the previously undiagnosed HCWs, 22 (2.7%) were seropositive. Seropositivity rates were highest for cleaning staff (6%), physicians (4%), nurses (2.2%) and radiology technicians (1%). Non-pandemic clinic (6.4%) and ICU (4.3%) had the highest prevalence. HCWs in "high risk" group had similar seropositivity rate with "no risk" group (2.9 vs 3.5 p = 0.7). These findings might lead to the re-evaluation of infection control and transmission dynamics in hospitals.

摘要

新型冠状病毒肺炎是一种具有日益增多感染病例的全球威胁。需要对卫生保健工作者(HCWs)的 IgG 血清流行率进行研究,以重新评估卫生政策。本研究在伊斯坦布尔和科贾埃利的三家大流行医院进行。对 SARS-CoV-2 感染的 HCWs 不同群体进行了筛查。通过化学发光微粒子免疫分析评估参与者的血清阳性率。我们招募了 813 名未感染和 119 名 PCR 确诊感染的 HCWs。在先前未诊断的 HCWs 中,有 22 名(2.7%)呈血清阳性。清洁人员(6%)、医生(4%)、护士(2.2%)和放射科技术人员(1%)的血清阳性率最高。非大流行科室(6.4%)和 ICU(4.3%)的患病率最高。“高危”组和“无风险”组的血清阳性率相似(2.9%比 3.5%,p=0.7)。这些发现可能导致重新评估医院的感染控制和传播动态。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d732/7928442/93244921c201/pone.0247865.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d732/7928442/47a2d25c41b7/pone.0247865.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d732/7928442/cf932466372e/pone.0247865.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d732/7928442/9c8b7794529e/pone.0247865.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d732/7928442/93244921c201/pone.0247865.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d732/7928442/47a2d25c41b7/pone.0247865.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d732/7928442/cf932466372e/pone.0247865.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d732/7928442/9c8b7794529e/pone.0247865.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d732/7928442/93244921c201/pone.0247865.g004.jpg

相似文献

1
Seroprevalence of coronavirus disease 2019 (COVID-19) among health care workers from three pandemic hospitals of Turkey.土耳其三家大流行医院医护人员中 2019 年冠状病毒病(COVID-19)血清流行率。
PLoS One. 2021 Mar 3;16(3):e0247865. doi: 10.1371/journal.pone.0247865. eCollection 2021.
2
[SARS-CoV-2 Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data From A University Hospital in Turkey].[土耳其一家大学医院医护人员中新冠病毒血清流行率:回顾性数据分析]
Mikrobiyol Bul. 2021 Apr;55(2):223-232. doi: 10.5578/mb.20219908.
3
Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.波兰一家儿科三级医院医护人员中针对 SARS-CoV-2 的 IgG 抗体流行率。
PLoS One. 2021 Apr 1;16(4):e0249550. doi: 10.1371/journal.pone.0249550. eCollection 2021.
4
Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.日本 COVID-19 大流行期间癌症患者与医护人员间 SARS-CoV-2 抗体状态的差异。
JAMA Oncol. 2021 Aug 1;7(8):1141-1148. doi: 10.1001/jamaoncol.2021.2159.
5
Risk factors for SARS-CoV-2 seropositivity in a health care worker population during the early pandemic.大流行早期医护人员人群中 SARS-CoV-2 血清阳性的风险因素。
BMC Infect Dis. 2023 May 16;23(1):330. doi: 10.1186/s12879-023-08284-y.
6
Higher rate of SARS-CoV-2 IgG seropositivity in hospital-based healthcare workers compared to elderly care staff in a Swedish low-prevalence region: a cross-sectional study.在瑞典低流行地区,与老年护理人员相比,医院医护人员的 SARS-CoV-2 IgG 血清阳性率更高:一项横断面研究。
Infect Dis (Lond). 2021 Nov-Dec;53(12):920-929. doi: 10.1080/23744235.2021.1959949. Epub 2021 Aug 5.
7
SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran.伊朗德黑兰有新冠患者转诊的主要私立和公立医院中卫生保健工作者的 SARS-CoV-2 血清流行率。
Front Public Health. 2022 Mar 24;10:832003. doi: 10.3389/fpubh.2022.832003. eCollection 2022.
8
SARS-CoV-2 seroprevalence in health care workers from 10 hospitals in Quebec, Canada: a cross-sectional study.加拿大魁北克省 10 家医院医护人员中 SARS-CoV-2 血清流行率:一项横断面研究。
CMAJ. 2021 Dec 13;193(49):E1868-E1877. doi: 10.1503/cmaj.202783.
9
Low seropositivity for SARS-CoV-2 antibodies among healthcare workers after the first COVID-19 pandemic wave in Greece.在希腊首次 COVID-19 大流行浪潮后,医护人员的 SARS-CoV-2 抗体血清阳性率较低。
Public Health. 2021 Sep;198:223-229. doi: 10.1016/j.puhe.2021.07.029. Epub 2021 Jul 31.
10
SARS-CoV-2 Seroprevalence Among Healthcare Workers by Job Function and Work Location in a New York Inner-City Hospital.在纽约市一家医院中,按工作职能和工作地点划分的医护人员中 SARS-CoV-2 血清流行率。
J Hosp Med. 2021 May;16(5):282-289. doi: 10.12788/jhm.3627.

引用本文的文献

1
Polymerase chain reaction-positivity and predictors for SARS-CoV-2 infection among diagnosed cases' in North West Ethiopia.埃塞俄比亚西北部确诊病例中新冠病毒聚合酶链反应阳性情况及感染预测因素
Health Sci Rep. 2023 Oct 26;6(10):e1663. doi: 10.1002/hsr2.1663. eCollection 2023 Oct.
2
[Risk management system to reduce COVID-19 infection in health personnelSistema de gestão de riscos para reduzir o contágio de COVID-19 em profissionais de saúde].降低医护人员感染新冠病毒的风险管理系统
Rev Panam Salud Publica. 2023 Aug 10;47:e114. doi: 10.26633/RPSP.2023.114. eCollection 2023.
3
Adherence of healthcare workers to COVID-19 infection prevention practices and its relationship with SARS-CoV-2 seropositivity.

本文引用的文献

1
Persistence of Anti-SARS-CoV-2 Antibodies in Non-Hospitalized COVID-19 Convalescent Health Care Workers.非住院COVID-19康复医护人员中抗SARS-CoV-2抗体的持久性
J Clin Med. 2020 Oct 1;9(10):3188. doi: 10.3390/jcm9103188.
2
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19.基于中性粒细胞与淋巴细胞比值和IgG水平的免疫表型分析可预测COVID-19患者的疾病严重程度和预后。
Front Mol Biosci. 2020 Jul 3;7:157. doi: 10.3389/fmolb.2020.00157. eCollection 2020.
3
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
医护人员对新冠病毒感染预防措施的依从性及其与新冠病毒血清阳性的关系。
J Infect Prev. 2023 May;24(3):119-131. doi: 10.1177/17571774231158782. Epub 2023 Mar 2.
4
A comparison of antibody response in kidney transplant recipients and healthcare workers who had PCR-confirmed COVID-19 infection.肾移植受者和经 PCR 确诊感染 COVID-19 的医护人员的抗体反应比较。
Turk J Med Sci. 2022 Dec;52(6):1754-1761. doi: 10.55730/1300-0144.5520. Epub 2022 Dec 21.
5
Specific COVID-19 risk behaviors and the preventive effect of personal protective equipment among healthcare workers in Japan.日本医护人员中特定的新冠病毒疾病风险行为及个人防护装备的预防效果
Glob Health Med. 2023 Feb 28;5(1):5-14. doi: 10.35772/ghm.2022.01060.
6
All Microbiological Aspects of SARS-CoV-2 Virus.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒的所有微生物学方面
Eurasian J Med. 2022 Dec;54(Suppl1):106-114. doi: 10.5152/eurasianjmed.2022.22315.
7
Seroepidemiology of SARS-CoV-2 Virus in Healthcare Workers before Circulation of the Omicron Sublineages BA.4/BA.5 in Vojvodina, Serbia.塞尔维亚伏伊伏丁那地区奥密克戎亚谱系BA.4/BA.5流行前医护人员中SARS-CoV-2病毒的血清流行病学研究
Vaccines (Basel). 2022 Dec 16;10(12):2168. doi: 10.3390/vaccines10122168.
8
A prevalence study of COVID-19 among healthcare workers in a pandemic hospital in the Samsun province of Turkey.土耳其萨姆松省一家大流行医院医护人员中 COVID-19 的流行率研究。
PLoS One. 2022 Dec 22;17(12):e0279067. doi: 10.1371/journal.pone.0279067. eCollection 2022.
9
Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chattogram Metropolitan Area, Bangladesh.孟加拉国吉大港市都会区抗SARS-CoV-2抗体的血清流行率
Antibodies (Basel). 2022 Nov 7;11(4):69. doi: 10.3390/antib11040069.
10
High Seroprevalence of SARS-CoV-2 in Mwanza, Northwestern Tanzania: A Population-Based Survey.坦桑尼亚西北部姆万扎的 SARS-CoV-2 高血清阳性率:一项基于人群的调查。
Int J Environ Res Public Health. 2022 Sep 16;19(18):11664. doi: 10.3390/ijerph191811664.
西班牙 2020 年人群血清流行病学研究(ENE-COVID):全国范围内基于人群的血清流行病学研究。
Lancet. 2020 Aug 22;396(10250):535-544. doi: 10.1016/S0140-6736(20)31483-5. Epub 2020 Jul 6.
4
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.无症状 SARS-CoV-2 感染的临床和免疫学评估。
Nat Med. 2020 Aug;26(8):1200-1204. doi: 10.1038/s41591-020-0965-6. Epub 2020 Jun 18.
5
Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium.比利时一家三级中心对 3056 名员工进行了医院范围的 SARS-CoV-2 抗体筛查。
JAMA. 2020 Jul 14;324(2):195-197. doi: 10.1001/jama.2020.11160.
6
Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines.抗击 COVID-19:诊断、治疗和疫苗的快速回顾。
Biomed J. 2020 Aug;43(4):341-354. doi: 10.1016/j.bj.2020.05.021. Epub 2020 May 30.
7
Responding to COVID-19 in Istanbul: Perspective from genomic laboratory.伊斯坦布尔应对新冠疫情:基因组实验室的视角
North Clin Istanb. 2020 May 7;7(3):311-312. doi: 10.14744/nci.2020.30075. eCollection 2020.
8
The time scale of asymptomatic transmission affects estimates of epidemic potential in the COVID-19 outbreak.无症状传播的时间尺度影响着对 COVID-19 疫情中流行潜力的估计。
Epidemics. 2020 Jun;31:100392. doi: 10.1016/j.epidem.2020.100392. Epub 2020 May 11.
9
Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset.感染 SARS-CoV-2 后的血清学特征:暴露后及症状出现后。
Eur Respir J. 2020 Aug 27;56(2). doi: 10.1183/13993003.00763-2020. Print 2020 Aug.
10
Modeling shield immunity to reduce COVID-19 epidemic spread.建立模型以减少新冠病毒的传播。
Nat Med. 2020 Jun;26(6):849-854. doi: 10.1038/s41591-020-0895-3. Epub 2020 May 7.